Pathologic outcome of incidentally detected tracer-avid lesions in 68Ga-PSMA-11 PET/CT for prostate cancer.

Darryl Mar, Devan Diwanji, Blair Lowery, Li Zhang, Thomas A Hope, Spencer C Behr, Robert R Flavell

800 Impact of 68Ga-PSMA-11 PET on the management of biochemically recurrent prostate cancer in a prospective single-arm clinical trial.

J. Ferdinandus, W.P. Fendler, J. Calais, M. Eiber, R.R. Flavell, A. Mishoe, F.Y. Feng, H.G. Nguyen, R.E. Reiter, M.B. Rettig, J. Gartmann, R. Smith, E.J. Small, R. Slavik, P.R. Carroll, K. Herrmann, J. Czernin, T.A. Hope